Details for Patent: 6,562,873
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 6,562,873 protect, and when does it expire?
Patent 6,562,873 protects ALPHAGAN P and is included in two NDAs.
Protection for ALPHAGAN P has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has twenty-seven patent family members in twenty-two countries.
Summary for Patent: 6,562,873
| Title: | Compositions containing therapeutically active components having enhanced solubility |
| Abstract: | Compositions which include therapeutically active components, solubility enhancing components other than cyclodextrins, and oxy-chloro components, wherein the oxy-chloro components are substantially effective as preservatives. In one embodiment, the oxy-chloro components are useful for preserving the therapeutically active components. In one embodiment, the oxy-chloro components include chlorite components. In a useful embodiment, the solubility enhancing components include carboxymethylcellulose. |
| Inventor(s): | Olejnik; Orest (Coto de Coza, CA), Kerslake; Edward D. S. (Charleston, MA) |
| Assignee: | Allergan, Inc. (Irvine, CA) |
| Application Number: | 09/903,962 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; |
Drugs Protected by US Patent 6,562,873
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | ALPHAGAN P | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 021770-001 | Aug 19, 2005 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Allergan | ALPHAGAN P | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 021262-001 | Mar 16, 2001 | AT | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,562,873
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 035039 | ⤷ Try a Trial | |||
| Australia | 2001273268 | ⤷ Try a Trial | |||
| Australia | 2005234735 | ⤷ Try a Trial | |||
| Australia | 7326801 | ⤷ Try a Trial | |||
| Brazil | 0112461 | ⤷ Try a Trial | |||
| Canada | 2416169 | ⤷ Try a Trial | |||
| China | 1441679 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
